Close

Wedbush Reiterates an 'Outperform' on Biodel (BIOD); Significant 2010 Catalysts

December 31, 2009 9:27 AM EST Send to a Friend
Wedbush reiterates an Outperform rating on Biodel (Nasdaq: BIOD), price target $17.

Wedbush analyst says, "Management submitted the NDA for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login